C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/18 (2006.01) A61K 31/41 (2006.01) A61K 31/475 (2006.01) A61K 31/55 (2006.01) A61K 31/56 (2006.01) A61K 31/70 (2006.01) A61K 33/24 (2006.01) A61K 38/19 (2006.01) C07H 21/00 (2006.01) C07K 14/475 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2112799
2112799 9300909 PCTABS00019 The present invention describes a method of treating neurotrophin-expressing tumors comprising interrupting the autocrine survival loop by administering a pharmaceutically effective amount of a substance capable of interrupting the autocrine loop. As examples, antisense nucleic acids and K252a or its derivatives may be used in pharmaceutically acceptable compositions, to interrupt the autocrine loop of a tumor cell which depends on the neurotrophin it expresses for its survival. A model system for identifying other means of interrupting autocrines loop is also described.
Nye Steven H.
Squinto Stephen P.
Yancopoulos George D.
Osler Hoskin & Harcourt Llp
Regeneron Pharmaceuticals Inc.
LandOfFree
Method and assay system for neurotrophin activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and assay system for neurotrophin activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and assay system for neurotrophin activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1772502